Endothelins. Vascular actions and clinical implications
- PMID: 7507031
- DOI: 10.2165/00003495-199346050-00001
Endothelins. Vascular actions and clinical implications
Similar articles
-
Endothelin-1: a potent vasoactive peptide.Pharmacol Toxicol. 1991 Nov;69(5):303-9. doi: 10.1111/j.1600-0773.1991.tb01302.x. Pharmacol Toxicol. 1991. PMID: 1803342 Review. No abstract available.
-
Endothelium-dependent vascular responses. Mediators and mechanisms.J Clin Invest. 1989 Nov;84(5):1373-8. doi: 10.1172/JCI114309. J Clin Invest. 1989. PMID: 2681265 Free PMC article. Review. No abstract available.
-
Endothelin in vascular biology.Ann N Y Acad Sci. 1994 Apr 18;714:101-8. doi: 10.1111/j.1749-6632.1994.tb12034.x. Ann N Y Acad Sci. 1994. PMID: 8017758 Review. No abstract available.
-
[The physio-pharmacological and pathological implications of the endothelins].Rev Med Chir Soc Med Nat Iasi. 1997 Jan-Jun;101(1-2):40-50. Rev Med Chir Soc Med Nat Iasi. 1997. PMID: 10756726 Review. Romanian.
-
The role of endothelin-1 in cardiovascular physiology and pathophysiology.Scott Med J. 1995 Jun;40(3):69-71. doi: 10.1177/003693309504000302. Scott Med J. 1995. PMID: 7569865 Review. No abstract available.
Cited by
-
Nitric oxide inhibits the production of soluble endothelin converting enzyme-1.Mol Cell Biochem. 2014 Nov;396(1-2):49-54. doi: 10.1007/s11010-014-2141-0. Epub 2014 Sep 17. Mol Cell Biochem. 2014. PMID: 25226840
-
Effects of endothelin receptor antagonists on bradykinin-induced increases in macromolecular efflux.Inflammation. 1994 Dec;18(6):633-44. doi: 10.1007/BF01535261. Inflammation. 1994. PMID: 7843806
-
Protein Kinase C Regulates the Cell Surface Activity of Endothelin-Converting Enzyme-1.Int J Pept Res Ther. 2006 Sep;12(3):291-295. doi: 10.1007/s10989-006-9034-3. Epub 2006 May 19. Int J Pept Res Ther. 2006. PMID: 19617920 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources